Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Update

Basel Medical Group Ltd (NASDAQ:BMGL) saw a large growth in short interest during the month of June. As of June 15th, there was short interest totaling 314,368 shares, a growth of 1,768.6% from the May 31st total of 16,824 shares. Approximately 20.2% of the company’s shares are short sold. Based on an average daily volume of 2,921,328 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of Basel Medical Group from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, June 15th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Basel Medical Group has an average rating of “Sell”.

Hedge Funds Weigh In On Basel Medical Group

Institutional investors have recently modified their holdings of the stock. Citadel Advisors LLC bought a new stake in shares of Basel Medical Group in the 3rd quarter valued at about $169,000. Virtu Financial LLC boosted its stake in Basel Medical Group by 108.8% during the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after acquiring an additional 17,608 shares during the last quarter. Finally, Marex Group plc bought a new position in Basel Medical Group during the 2nd quarter worth approximately $25,000.

Basel Medical Group Stock Down 4.6%

Shares of NASDAQ:BMGL traded down $0.32 during midday trading on Thursday, hitting $6.71. The company had a trading volume of 6,483 shares, compared to its average volume of 150,642. Basel Medical Group has a 12 month low of $4.60 and a 12 month high of $54.60. The firm has a fifty day simple moving average of $7.45 and a 200 day simple moving average of $7.77.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.